595 related articles for article (PubMed ID: 32508821)
1. The Role of NLRP3 Inflammasome Activation in the Epithelial to Mesenchymal Transition Process During the Fibrosis.
Alyaseer AAA; de Lima MHS; Braga TT
Front Immunol; 2020; 11():883. PubMed ID: 32508821
[TBL] [Abstract][Full Text] [Related]
2. Paricalcitol attenuates TGF-β1-induced phenotype transition of human peritoneal mesothelial cells (HPMCs) via modulation of oxidative stress and NLRP3 inflammasome.
Ko J; Kang HJ; Kim DA; Ryu ES; Yu M; Lee H; Lee HK; Ryu HM; Park SH; Kim YL; Kang DH
FASEB J; 2019 Feb; 33(2):3035-3050. PubMed ID: 30354670
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin(1-7) attenuated Angiotensin II-induced hepatocyte EMT by inhibiting NOX-derived H2O2-activated NLRP3 inflammasome/IL-1β/Smad circuit.
Zhang LL; Huang S; Ma XX; Zhang WY; Wang D; Jin SY; Zhang YP; Li Y; Li X
Free Radic Biol Med; 2016 Aug; 97():531-543. PubMed ID: 27445100
[TBL] [Abstract][Full Text] [Related]
4. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
[TBL] [Abstract][Full Text] [Related]
5. NLRP3 inflammasome inhibition attenuates silica-induced epithelial to mesenchymal transition (EMT) in human bronchial epithelial cells.
Li X; Yan X; Wang Y; Wang J; Zhou F; Wang H; Xie W; Kong H
Exp Cell Res; 2018 Jan; 362(2):489-497. PubMed ID: 29258746
[TBL] [Abstract][Full Text] [Related]
6. C3a/C3aR synergies with TGF-β to promote epithelial-mesenchymal transition of renal tubular epithelial cells via the activation of the NLRP3 inflammasome.
You D; Nie K; Wu X; Weng M; Yang L; Chen Y; Cui J; Wan J
J Transl Med; 2023 Dec; 21(1):904. PubMed ID: 38082306
[TBL] [Abstract][Full Text] [Related]
7. Uric acid activates NRLP3 inflammasome in an in-vivo model of epithelial to mesenchymal transition in the kidney.
Romero CA; Remor A; Latini A; De Paul AL; Torres AI; Mukdsi JH
J Mol Histol; 2017 Jun; 48(3):209-218. PubMed ID: 28374152
[TBL] [Abstract][Full Text] [Related]
8. [Triptolide inhibits NLRP3 inflammasome activation and ameliorates podocyte epithelial-mesenchymal transition induced by high glucose].
Wu W; Liu BH; Wan YG; Sun W; Liu YL; Wang WW; Fang QJ; Tu Y; Yee HY; Yuan CC; Wan ZY
Zhongguo Zhong Yao Za Zhi; 2019 Dec; 44(24):5457-5464. PubMed ID: 32237395
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effect of modulating the NLRP3-regulated transforming growth factor-β signaling pathway on interstitial cystitis/bladder pain syndrome.
Shih HJ; Chang CY; Lai CH; Huang CJ
Biomed Pharmacother; 2021 Jun; 138():111522. PubMed ID: 34311526
[TBL] [Abstract][Full Text] [Related]
10. Inflammasome-independent NLRP3 augments TGF-β signaling in kidney epithelium.
Wang W; Wang X; Chun J; Vilaysane A; Clark S; French G; Bracey NA; Trpkov K; Bonni S; Duff HJ; Beck PL; Muruve DA
J Immunol; 2013 Feb; 190(3):1239-49. PubMed ID: 23264657
[TBL] [Abstract][Full Text] [Related]
11. Contribution of Autophagy-Notch1-Mediated NLRP3 Inflammasome Activation to Chronic Inflammation and Fibrosis in Keloid Fibroblasts.
Lee S; Kim SK; Park H; Lee YJ; Park SH; Lee KJ; Lee DG; Kang H; Kim JE
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33126764
[TBL] [Abstract][Full Text] [Related]
12. Relevant mediators involved in and therapies targeting the inflammatory response induced by activation of the NLRP3 inflammasome in ischemic stroke.
Xu Q; Zhao B; Ye Y; Li Y; Zhang Y; Xiong X; Gu L
J Neuroinflammation; 2021 May; 18(1):123. PubMed ID: 34059091
[TBL] [Abstract][Full Text] [Related]
13. Cell-Specific Roles of NLRP3 Inflammasome in Myocardial Infarction.
Takahashi M
J Cardiovasc Pharmacol; 2019 Sep; 74(3):188-193. PubMed ID: 31356542
[TBL] [Abstract][Full Text] [Related]
14. NLRP3 Inflammasome in Acute Myocardial Infarction.
Mauro AG; Bonaventura A; Mezzaroma E; Quader M; Toldo S
J Cardiovasc Pharmacol; 2019 Sep; 74(3):175-187. PubMed ID: 31356555
[TBL] [Abstract][Full Text] [Related]
15. The NLRP3 Inflammasome as a Pharmacological Target.
Marchetti C
J Cardiovasc Pharmacol; 2019 Oct; 74(4):285-296. PubMed ID: 31335445
[TBL] [Abstract][Full Text] [Related]
16. Huangkui capsule alleviates renal tubular epithelial-mesenchymal transition in diabetic nephropathy via inhibiting NLRP3 inflammasome activation and TLR4/NF-κB signaling.
Han W; Ma Q; Liu Y; Wu W; Tu Y; Huang L; Long Y; Wang W; Yee H; Wan Z; Tang R; Tang H; Wan Y
Phytomedicine; 2019 Apr; 57():203-214. PubMed ID: 30785016
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of NLRP3 alleviates high glucose or TGFB1-induced EMT in human renal tubular cells.
Song S; Qiu D; Luo F; Wei J; Wu M; Wu H; Du C; Du Y; Ren Y; Chen N; Duan H; Shi Y
J Mol Endocrinol; 2018 Oct; 61(3):101-113. PubMed ID: 30307163
[TBL] [Abstract][Full Text] [Related]
18. IAPP/amylin deposition, which is correlated with expressions of ASC and IL-1β in β-cells of Langerhans' islets, directly initiates NLRP3 inflammasome activation.
Morikawa S; Kaneko N; Okumura C; Taguchi H; Kurata M; Yamamoto T; Osawa H; Nakanishi A; Zako T; Masumoto J
Int J Immunopathol Pharmacol; 2018; 32():2058738418788749. PubMed ID: 30014749
[TBL] [Abstract][Full Text] [Related]
19. Inflammasome-independent NLRP3 is required for epithelial-mesenchymal transition in colon cancer cells.
Wang H; Wang Y; Du Q; Lu P; Fan H; Lu J; Hu R
Exp Cell Res; 2016 Mar; 342(2):184-92. PubMed ID: 26968633
[TBL] [Abstract][Full Text] [Related]
20. Interplay Between NLRP3 Inflammasome and Autophagy.
Biasizzo M; Kopitar-Jerala N
Front Immunol; 2020; 11():591803. PubMed ID: 33163006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
